PAVmed, Inc. (PAVM)
5.02
-0.16
(-3.00%)
USD |
NASDAQ |
Aug 24, 16:00
5.02
0.00 (0.00%)
After-Hours: 20:00
PAVmed Enterprise Value : 33.84M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 33.84M |
| August 20, 2026 | 33.87M |
| August 19, 2026 | 33.37M |
| August 18, 2026 | 33.12M |
| August 17, 2026 | 34.78M |
| August 14, 2026 | 33.99M |
| August 13, 2026 | 31.11M |
| August 12, 2026 | 27.79M |
| August 11, 2026 | 30.92M |
| August 10, 2026 | 31.17M |
| August 07, 2026 | 31.11M |
| August 06, 2026 | 32.36M |
| August 05, 2026 | 32.99M |
| August 04, 2026 | 32.99M |
| August 03, 2026 | 35.87M |
| July 31, 2026 | 32.43M |
| July 30, 2026 | 33.09M |
| July 29, 2026 | 33.37M |
| July 28, 2026 | 35.12M |
| July 27, 2026 | 33.99M |
| July 24, 2026 | 31.11M |
| July 23, 2026 | 29.86M |
| July 22, 2026 | 30.98M |
| July 21, 2026 | 36.13M |
| July 20, 2026 | 37.69M |
| Date | Value |
|---|---|
| July 17, 2026 | 38.54M |
| July 16, 2026 | 39.13M |
| July 15, 2026 | 39.64M |
| July 14, 2026 | 36.94M |
| July 13, 2026 | 35.87M |
| July 10, 2026 | 36.50M |
| July 09, 2026 | 36.19M |
| July 08, 2026 | 35.09M |
| July 07, 2026 | 34.31M |
| July 06, 2026 | 34.75M |
| July 02, 2026 | 37.19M |
| July 01, 2026 | 40.89M |
| June 30, 2026 | 38.63M |
| June 29, 2026 | 33.38M |
| June 26, 2026 | 31.43M |
| June 25, 2026 | 27.04M |
| June 24, 2026 | 29.05M |
| June 23, 2026 | 29.11M |
| June 22, 2026 | 30.55M |
| June 18, 2026 | 32.12M |
| June 17, 2026 | 31.12M |
| June 16, 2026 | 31.02M |
| June 15, 2026 | 30.05M |
| June 12, 2026 | 31.12M |
| June 11, 2026 | 30.43M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 229.49B |
| AngioDynamics, Inc. | 613.87M |
| Alphatec Holdings, Inc. | 1.956B |
| AtriCure, Inc. | 2.398B |
| Baxter International, Inc. | 20.30B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.598M |
| Revenue (Quarterly) | 0.033M |
| Total Expenses (Quarterly) | 5.417M |
| EPS Diluted (Quarterly) | -0.8739 |
| Gross Profit Margin (Quarterly) | -327.3% |
| Profit Margin (Quarterly) | -19.99K% |
| Earnings Yield | -328.1% |
| Normalized Earnings Yield | -258.90 |